Exact Mass: 264.1474
Exact Mass Matches: 264.1474
Found 69 metabolites which its exact mass value is equals to given mass value 264.1474,
within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error
8.0E-6 dalton.
Subaphylline
Alkaloid from Ananas comosus (pineapple). Subaphylline is found in many foods, some of which are pineapple, sweet orange, corn, and fruits. Subaphylline is found in avocado. Subaphylline is an alkaloid from Ananas comosus (pineapple). CASMI2013 Challenge_2 MS2 data; [MS1] MSJ00003 CASMI2013 Challenge_2 MS1 data; [MS2] MSJ00004
Phenylalanylvaline
Phenylalanylvaline is a dipeptide composed of phenylalanine and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Valylphenylalanine
Valylphenylalanine is a dipeptide composed of valine and phenylalanine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Vorinostat
Vorinostat (rINN) or suberoylanilide hydroxamic acid (SAHA), is a drug currently under investigation for the treatment of cutaneous T cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines. It is the first in a new class of agents known as histone deacetylase inhibitors. A recent study suggested that vorinostat also possesses some activity against recurrent glioblastoma multiforme, resulting in a median overall survival of 5.7 months (compared to 4 - 4.4 months in earlier studies). Further brain tumor trials are planned in which vorinostat will be combined with other drugs. [Wikipedia] L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XH - Histone deacetylase (hdac) inhibitors D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents
5-(Cycloocten-1-yl)-5-ethyl-barbituric acid
Propacetamol
N - Nervous system > N02 - Analgesics > N02B - Other analgesics and antipyretics > N02BE - Anilides C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
3-Isobutyryl-6,7-dihydro-2-isopropylpyrazolo[1,5-a]pyridine-6,7-diol
2-[(2-amino-3-methylbutanoyl)amino]-3-phenylpropanoic acid
LID_265.1546_9.2
CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 803 INTERNAL_ID 803; CONFIDENCE Tentative identification: most likely structure (Level 3)
Vorinostat
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XH - Histone deacetylase (hdac) inhibitors D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents
2H-Indol-2-one, 1,3-dihydro-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-
Phe-Val
A dipeptide formed from L-phenylalanine and L-valine residues.
Val-phe
A dipeptide formed from L-valine and L-phenylalanine residues.
tert-Butyl 2-methyl-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-ylcarbamate
1-[2-AMINO-1-(2-METHOXY-PHENYL)-ETHYL]-PYRROLIDINE-3-CARBOXYLICACID
4-Boc-7-Hydroxy-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine
tert-butyl N-(5-methoxy-4-prop-2-enylpyridin-3-yl)carbamate
TERT-BUTYL 5-METHOXY-3,4-DIHYDRO-1,7-NAPHTHYRIDINE-1(2H)-CARBOXYLATE
TERT-BUTYL 6-METHOXY-3,4-DIHYDROQUINOXALINE-1(2H)-CARBOXYLATE
(R)-TERT-BUTYL (1-AMINO-1-OXO-3-PHENYLPROPAN-2-YL)CARBAMATE
2-(4-MORPHOLINYL)-PYRIDINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER
Carbamic acid, N-[[4-[(hydroxyimino)methyl]phenyl]methyl]-N-methyl-, 1,1-dimethylethyl ester
(S)-BENZYL (1-AMINO-4-METHYL-1-OXOPENTAN-2-YL)CARBAMATE
2-(4-AMINO-1-(3-METHOXYPHENYL)PIPERIDIN-4-YL)ACETIC ACID
2-(4-AMINO-1-(4-METHOXYPHENYL)PIPERIDIN-4-YL)ACETIC ACID
2-(2-amino-3-phenylpropanamido)-3-methylbutanoic acid
4-[[Diethylamino(oxo)methyl]amino]benzoic acid ethyl ester
Propacetamol
N - Nervous system > N02 - Analgesics > N02B - Other analgesics and antipyretics > N02BE - Anilides C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
